The Role of Targeted Therapy in Metastatic Renal Cell Carcinoma
Renal cell carcinoma (RCC) is a highly vascular tumor in which a growing understanding of disease biology has been translated into clinically active systemic therapies. The most clinically developed targeted therapies in advanced RCC are those that target the vascular endothelial growth factor (VEGF...
Saved in:
Main Authors: | Jaya Unnithan, Brian I. Rini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2007.149 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy
by: Abhishek Bhat, et al.
Published: (2019-01-01) -
Metastatic Lesion of the Tibia from Renal Cell Carcinoma
by: Piotr Młodożeniec, et al.
Published: (2021-01-01) -
Is It Safe to Restart Antivascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma after Cardiac Ischemia?
by: Bo Zhao, et al.
Published: (2015-01-01) -
Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy
by: Xinwei Li, et al.
Published: (2025-01-01) -
Bilateral Asynchronous Renal Cell Carcinoma with Metastatic Involvement of the Tongue
by: Naseem Ghazali, et al.
Published: (2012-01-01)